Cervical cancer is one of the most common carcinomas in the female population; second in frequency. In the female population it makes up 12% of all malignant diseases. In general it takes the third place in frequency and ahead of it is the breast carcinoma and the colorectal carcinoma. Data accessed by WHO (World Health Organization) indicates that every year in the world around half a million women suffers cervical cancer, which is a significant number, of which 230.000, unfortunately, ends with lethal outcome, 83% of which comes from developing countries. In Montenegro, in 2006, 974 women died due to malignant neoplasm. In Europe, 65.000 women suffers cervical cancer, and 32.000 dies a in a year, with a significant increase in incidence and mortality in the last few years with younger population.
Nacionalni program za rano otkrivanje karcdinoma grlića materice. 2011;
2.
List of Classifications by cancer sites with sufficient or limited evidence in humans(link is external). Volumes 1 to 105.
3.
Hoover R, Hyer M, Pfeiffer R. Adverse health outcomes in women exposed in utero to diethylstilbestrol.(link is external). N Engl J Med. 2011;(14):1304–14.
4.
Cust A. Physical activity and gynecologic cancer prevention(link is external). Recent Results Cancer Res. 2011;159–85.
5.
Lee J, So K, Piyathilake C, Kim M. Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer(link is external). PLoS One. 2013;(6):66555.
6.
Hussain S, Sundquist J, Hemminki K. Familial clustering of cancer at human papillomavirus-associated sites according to the Swedish Family-Cancer Database(link is external). Int J Cancer. 2008;(8):1873–8.
7.
Jensen K, Thomsen L, Schmiedel S. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study(link is external). Sex Transm Infect. 2014;
8.
9.
Zeng X, Xiong P, Wang F, Li C, Yao J, Guo Y. Passive smoking and cervical cancer risk: a meta-analysis based on 3,230 cases and 2,982 controls (link is external). Asian Pac J Cancer Prev. 2012;(6):2687–93.
10.
Vaccarella Herrero R, Pj. Smoking and human papillomavirus infection: pooled analysis of the International Agency Research on Cancer HPV Prevalence Surveys(link is external). Int J Epidemiol. 2008;(3):536–46.
11.
Anderson L, ’rorke O, M, Wilson J, Gavin R, A. HPV Working Group members Prevalence of human papillomavirus in women attending cervical screening in the UK and Ireland: new data from northern Ireland and a systematic review and meta-analysis(link is external). J Med Virol. 2013;(2):295–308.
12.
Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. 2008;(2).
13.
Sasieni P, Castanon A, Parkin D. How many cervical cancers are prevented by treatment of screen-detected disease in young women?(link is external. Int J Cancer. 2009;(2):461–4.
14.
Vecchia L, Boccia C, S. Oral contraceptives, human papillomavirus and cervical cancer(link is external). Eur J Cancer Prev. 2014;(2):110–2.
15.
Centre C, Prevention. Cancers attributable to exposure to hormones in the UK in 2010(link is external). Br J Cancer. 2011;(Suppl 2):42–8.
16.
Gierisch J, Coeytaux R, Urrutia R. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review(link is external). Cancer Epidemiol Biomarkers Prev. 2013;(11):1931–43.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
